Prof. Ruirui Qiao


Name:

Ruirui Qiao

Title:

Senior Research Fellow

Affiliation:

The University of   Queensland

Email:

r.qiao@uq.edu.au

100-word biography:

Dr.   Ruirui Qiao is a Group leader and NHMRC Emerging Leadership fellow at   Australian Institute for Bioengineering and Nanotechnology (AIBN), The   University of Queensland. She received her BSc (2005) and MSc (2007) in   pharmaceutical science in Peking University in China. From 2007 to 2016, she   worked as a research assistant and associate in Institute of Chemistry,   Chinese Academy of Science (CAS). In 2016, she was promoted to be an   associated Professor in Chinese Academy of Sciences. In 2017, she joined   Monash Institute of Pharmaceutical Sciences (MIPS) as a research fellow   within ARC Centre of Bio-Nano Science (CBNS) under the leadership and   mentorship of Professor Tom Davis. In 2019, she relocated to AIBN as the   co-project leader of CBNS. In 2021, she received the prestigious UQ   Foundation Research Excellence Award. Her research focuses on the development   of polymeric/inorganic nanohybrids and assemblies for disease diagnosis and   therapy.

Lecture Title:

Polymeric/inorganic nanohybrids:   attractive materials as molecular imaging probes

Abstract:

Hybrid   nanomaterials, with an inorganic core and organic surface coating, has shown   great potential in a number of fields such as health, environment,   microfluidics, as well as imaging and targeting delivery. Instead of   utilising solely functions from either metal-based inorganic materials (e.g.   Iron oxides, upconversion nanoparticles (UCNPs), Au nanoparticles, quantum   dots, liquid metal nanoparticles (LMNPs), etc.) or organic polymers with   unique properties (e.g. biocompatibility, chemical or biochemical reactivity,   optical or electrical characteristics), hybrid functional materials involve a   synergic combination of two chemical worlds to generate new materials with   improved performance or even novel properties. In bioapplications such as   imaging or targeting delivery, the advantages of hybrid nanoparticle-based   imaging agents include tailorable size and surface, high loading capacity,   controllable or environmental responsive signal activation, reduced side   effect and improved biocompatibility.

The   seminar will cover the design and fabrication of different types of   functional polymeric/inorganic nanohybrids as imaging probes for diagnosis of   diseases.

Other: